0
0
0
EFFECTIVE Act
3/13/2024, 11:23 AM
Congressional Summary of S 607
Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act
This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug (i.e., opioid medication) upon a determination that the drug does not provide a significant advantage with respect to safety or effectiveness as compared to other drugs.
Read the Full Bill
Current Status of Bill S 607
Bill S 607 is currently in the status of Bill Introduced since March 1, 2023. Bill S 607 was introduced during Congress 118 and was introduced to the Senate on March 1, 2023. Bill S 607's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 1, 2023
Bipartisan Support of Bill S 607
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
1Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 607
Primary Policy Focus
HealthAlternate Title(s) of Bill S 607
EFFECTIVE Act
EFFECTIVE Act
Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act
A bill to allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.
Comments
Sponsors and Cosponsors of S 607
Latest Bills
Providing amounts for the expenses of the Committee on Ethics in the One Hundred Nineteenth Congress.
Bill HRES 131December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Central Yukon Record of Decision and Approved Resource Management Plan".
Bill HJRES 106December 12, 2025
Expressing the sense of the House of Representatives in condemning the Government of the People's Republic of China for its harassment and efforts to intimidate American citizens and other individuals on United States soil with the goal of suppressing speech and narratives the People's Republic of China finds unwelcome.
Bill HRES 130December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "North Dakota Field Office Record of Decision and Approved Resource Management Plan".
Bill HJRES 105December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Miles City Field Office Record of Decision and Approved Resource Management Plan Amendment".
Bill HJRES 104December 12, 2025
Providing amounts for the expenses of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party in the One Hundred Nineteenth Congress.
Bill HRES 104December 12, 2025
Critical Access for Veterans Care Act
Bill S 1868December 12, 2025
OATH Act of 2025
Bill S 1665December 12, 2025
A bill to extend the authority for modifications to the Second Division Memorial in the District of Columbia.
Bill S 1353December 12, 2025
Saving Our Veterans Lives Act of 2025
Bill S 926December 12, 2025
EFFECTIVE Act
Bill HR 1375December 15, 2023